Inventor · disambiguated record
Scott Alan Mccauley
Also filed as: MCCAULEY SCOTT · MCCAULEY SCOTT ALAN
20 granted patents·18 pending applications·176 citations·filing 2008–2023
95Inventor score
Files withGILEAD BIOLOGICS INC17SYNTHEKINE INC7SMITH VICTORIA4ARMO BIOSCIENCES INC3GILEAD SCIENCES INC2
Top patents by PatentIndex Score
38 records- 0194US8927700B2Catalytic domains from lysyl oxidase and LOXL2GILEAD BIOLOGICS INC·Filed 2013·Granted Jan 6, 2015·17 cites·10 claims
- 0294US8461303B2LOX and LOXL2 inhibitors and uses thereofSMITH VICTORIA·Filed 2008·Granted Jun 11, 2013·30 cites·30 claims
- 0393US8658167B2Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisGILEAD BIOLOGICS INC·Filed 2012·Granted Feb 25, 2014·19 cites·30 claims
- 0492US9176139B2LOX and LOXL2 inhibitors and uses thereofGILEAD BIOLOGICS INC·Filed 2013·Granted Nov 3, 2015·16 cites·60 claims
- 0592US8377443B2Antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2011·Granted Feb 19, 2013·21 cites·7 claims
- 0691US10350270B2Interleukin-15 compositions and uses thereofARMO BIOSCIENCES INC·Filed 2015·Granted Jul 16, 2019·14 cites·25 claims
- 0790US11491205B2Biased IL2 muteins methods and compositionsSYNTHEKINE INC·Filed 2021·Granted Nov 8, 2022·4 cites·18 claims
- 0889US10800857B2Antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2019·Granted Oct 13, 2020·2 cites·16 claims
- 0988US8680246B2Antibodies that bind to lysyl oxidase-like 2 (LOXL2)MCCAULEY SCOTT ALAN·Filed 2011·Granted Mar 25, 2014·17 cites·27 claims
- 1086US9120863B2Nucleic acids encoding antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2013·Granted Sep 1, 2015·7 cites·30 claims
- 1186US8679485B2Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisSMITH VICTORIA·Filed 2008·Granted Mar 25, 2014·6 cites·44 claims
- 1286US8501916B2Antibodies to matrix metalloproteinase 9MCCAULEY SCOTT·Filed 2012·Granted Aug 6, 2013·8 cites·16 claims
- 1384US9260532B2Antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2013·Granted Feb 16, 2016·6 cites·11 claims
- 1483US9550836B2Method of detecting human matrix metalloproteinase 9 using antibodiesSMITH VICTORIA·Filed 2012·Granted Jan 24, 2017·5 cites·9 claims
- 1581US8512990B2Catalytic domains from lysyl oxidase and LOXL2MCCAULEY SCOTT·Filed 2010·Granted Aug 20, 2013·4 cites·11 claims
- 1675US12440540B2IL-2 orthologs and methods of useSYNTHEKINE INC·Filed 2023·Granted Oct 14, 2025·0 cites·8 claims
- 1773US11634505B2Antibodies to matrix metalloproteinase 9GILEAD SCIENCES INC·Filed 2020·Granted Apr 25, 2023·0 cites·13 claims
- 1864US10494443B2LOX and LOXL2 inhibitors and uses thereofGILEAD BIOLOGICS INC·Filed 2016·Granted Dec 3, 2019·0 cites·22 claims
- 1964US2025042966A1Il10 variants and uses thereofSYNTHEKINE INC·Filed 2022·Application pending·0 cites
- 2064US2014128284A1Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisGILEAD BIOLOGICS INC·Filed 2013·Application pending·0 cites
- 2164US2014349309A1Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisGILEAD BIOLOGICS INC·Filed 2014·Application pending·0 cites
- 2262US11648296B2IL-2 orthologs and methods of useSYNTHEKINE INC·Filed 2020·Granted May 16, 2023·0 cites·2 claims
- 2362US2023031597A1Biased il2 muteins methods and compositionsSYNTHEKINE INC·Filed 2022·Application pending·0 cites
- 2462US2025388640A1Human il-12p40 variants and uses thereofSYNTHEKINE INC·Filed 2022·Application pending·0 cites
- 2561US2018086845A1Nucleic acids encoding antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 2658US2012087917A1Lox and loxl2 inhibitors and uses thereofSMITH VICTORIA·Filed 2011·Application pending·0 cites
- 2757US2016185877A1Lox and loxl2 inhibitors and uses thereofGILEAD BIOLOGICS INC·Filed 2015·Application pending·0 cites
- 2857US2016122437A1Antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 2956US2016159923A1Antibodies to matrix metalloproteinase 9GILEAD BIOLOGICS INC·Filed 2015·Application pending·0 cites
- 3056US2017183421A1Method of detecting human matrix metalloproteinase 9 using antibodiesGILEAD BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3156US2014255951A1Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use thereforGILEAD BIOLOGICS INC·Filed 2014·Application pending·0 cites
- 3256US2014302524A1Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use thereforGILEAD BIOLOGICS INC·Filed 2014·Application pending·0 cites
- 3349US2021347842A1Compositions and methods of use of il-10 agents in conjunction with chimeric antigen receptor cell therapyLILLY CO ELI·Filed 2019·Application pending·0 cites
- 3446US11814679B2Interleukin-10 production of antigen-specific CD8+ T cells and methods of use of sameLILLY CO ELI·Filed 2017·Granted Nov 14, 2023·0 cites·13 claims
- 3546US2023210951A1Il2 muteinsSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 3645US2016068583A1Interleukin-10 Compositions and Uses ThereofARMO BIOSCIENCES INC·Filed 2014·Application pending·0 cites
- 3744US2014086913A1Anti-ddr1 antibodiesGILEAD SCIENCES INC·Filed 2013·Application pending·0 cites
- 3839US2018360977A1Interleukin-15 Compositions and Uses ThereofARMO BIOSCIENCES INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Alan Mccauley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →